These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20447923)

  • 1. Folate intake along with genetic polymorphisms in methylenetetrahydrofolate reductase and thymidylate synthase in patients with advanced gastric cancer.
    Shitara K; Muro K; Ito S; Sawaki A; Tajika M; Kawai H; Yokota T; Takahari D; Shibata T; Ura T; Ito H; Hosono S; Kawase T; Watanabe M; Tajima K; Yatabe Y; Tanaka H; Matsuo K
    Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1311-9. PubMed ID: 20447923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population.
    Huang ZH; Hua D; Li LH
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):911-8. PubMed ID: 18704422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary folate and vitamin B12 intake before diagnosis decreases gastric cancer mortality risk among susceptible MTHFR 677TT carriers.
    Galván-Portillo MV; Oñate-Ocaña LF; Pérez-Pérez GI; Chen J; Herrera-Goepfert R; Chihu-Amparan L; Flores-Luna L; Mohar-Betancourt A; López-Carrillo L
    Nutrition; 2010 Feb; 26(2):201-8. PubMed ID: 19577428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms on the disease-free survival of breast cancer patients receiving adjuvant 5-fluorouracil/methotrexate-based therapy.
    Paré L; Altés A; Ramón y Cajal T; Del Rio E; Alonso C; Sedano L; Barnadas A; Baiget M
    Anticancer Drugs; 2007 Aug; 18(7):821-5. PubMed ID: 17581305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.
    Lecomte T; Ferraz JM; Zinzindohoué F; Loriot MA; Tregouet DA; Landi B; Berger A; Cugnenc PH; Jian R; Beaune P; Laurent-Puig P
    Clin Cancer Res; 2004 Sep; 10(17):5880-8. PubMed ID: 15355920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients.
    Sharma R; Hoskins JM; Rivory LP; Zucknick M; London R; Liddle C; Clarke SJ
    Clin Cancer Res; 2008 Feb; 14(3):817-25. PubMed ID: 18245544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.
    Ott K; Rachakonda PS; Panzram B; Keller G; Lordick F; Becker K; Langer R; Buechler M; Hemminki K; Kumar R
    Ann Surg Oncol; 2011 Sep; 18(9):2688-98. PubMed ID: 21347786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of methylenetetrahydrofolate reductase gene polymorphisms and sex-specific survival in patients with metastatic colon cancer.
    Zhang W; Press OA; Haiman CA; Yang DY; Gordon MA; Fazzone W; El-Khoueiry A; Iqbal S; Sherrod AE; Lurje G; Lenz HJ
    J Clin Oncol; 2007 Aug; 25(24):3726-31. PubMed ID: 17704422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in Korean patients with gastric cancer].
    Lee J; Jeong CK; Hong SP; Chong SY; Oh D; Hwang SG; Ahn DH; Kim S; Han JH; Kim NK
    Korean J Gastroenterol; 2005 Jul; 46(1):32-8. PubMed ID: 16030402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer.
    Smit EF; Burgers SA; Biesma B; Smit HJ; Eppinga P; Dingemans AM; Joerger M; Schellens JH; Vincent A; van Zandwijk N; Groen HJ
    J Clin Oncol; 2009 Apr; 27(12):2038-45. PubMed ID: 19307503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)--novel predictors for response and survival in gastric cancer patients.
    Goekkurt E; Hoehn S; Wolschke C; Wittmer C; Stueber C; Hossfeld DK; Stoehlmacher J
    Br J Cancer; 2006 Jan; 94(2):281-6. PubMed ID: 16317430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylenetetrahydrofolate reductase polymorphism is associated with folate pool in gastrointestinal cancer tissue.
    Kawakami K; Omura K; Kanehira E; Watanabe G
    Anticancer Res; 2001; 21(1A):285-9. PubMed ID: 11299748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-carbon metabolism-related gene polymorphisms and risk of breast cancer.
    Suzuki T; Matsuo K; Hirose K; Hiraki A; Kawase T; Watanabe M; Yamashita T; Iwata H; Tajima K
    Carcinogenesis; 2008 Feb; 29(2):356-62. PubMed ID: 18174236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the ingestion of folate and polymorphism of MTHFR C677T with esophageal cancer in Xinjiang Kazakh].
    Qin JM; Wang XM; Chen B; Yang L; Li F; He L; Liao PH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jan; 29(1):30-3. PubMed ID: 18785474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study.
    Lin J; Spitz MR; Wang Y; Schabath MB; Gorlov IP; Hernandez LM; Pillow PC; Grossman HB; Wu X
    Carcinogenesis; 2004 Sep; 25(9):1639-47. PubMed ID: 15117811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy?
    Marcuello E; Altés A; Menoyo A; Rio ED; Baiget M
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):835-40. PubMed ID: 16187112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MTHFR polymorphisms, dietary folate intake and risks to breast cancer].
    Gao CM; Kazuo T; Tang JH; Cao HX; Ding JH; Wu JZ; Wang J; Liu YT; Li SP; Su P; Keitaro M; Toshiro T
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):576-80. PubMed ID: 19954067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study.
    Shen H; Spitz MR; Wang LE; Hong WK; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):397-401. PubMed ID: 11319182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort.
    Ericson U; Sonestedt E; Ivarsson MI; Gullberg B; Carlson J; Olsson H; Wirfält E
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1101-10. PubMed ID: 19336565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polymorphism of methylenetetrahydrofolate reductase and sensitivity of stomach cancer to fluoropyrimidine-based chemotherapy].
    Gao CM; Lu JW; Toshiro T; Wu JZ; Cao HX; Chen HQ; Feng JF; Kazuo T
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1054-8. PubMed ID: 15769364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.